𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Motexafin gadolinium (MGd) overcomes adverse survival effect of anemia in brain metastases (BM) patients treated with whole brain radiation therapy (WBRT): analysis of a phase III randomized trial

✍ Scribed by P Kumar; M.P Mehta; P Rodrigus; J Suh; S Sagar; I Kunkler; C Carrie; J.A Smith; S Phan; M.F Renschler


Book ID
108435244
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
36 KB
Volume
57
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.